Application 217720
- Type
- ANDA
- Sponsor
- QILU PHARM HAINAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | POSACONAZOLE | POSACONAZOLE | TABLET, DELAYED RELEASE;ORAL | 100MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A217720-001 | POSACONAZOLE | POSACONAZOLE | 100MG | TABLET, DELAYED RELEASE / ORAL | AB | 2025-04-23 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A217720-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A217720-001 | POSACONAZOLE | 100MG | TABLET, DELAYED RELEASE / ORAL | AB | 2025-04-23 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A217720-001 | POSACONAZOLE | 100MG | TABLET, DELAYED RELEASE / ORAL | AB | 2025-04-23 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A217720-001 | POSACONAZOLE | 100MG | TABLET, DELAYED RELEASE / ORAL | AB | 2025-04-23 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A217720-001 | POSACONAZOLE | 100MG | TABLET, DELAYED RELEASE / ORAL | AB | 2025-04-23 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A217720-001 | POSACONAZOLE | 100MG | TABLET, DELAYED RELEASE / ORAL | AB | 2025-04-23 | 6a471c1ec25d… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A217720-001 | POSACONAZOLE | 100MG | TABLET, DELAYED RELEASE / ORAL | AB | 2025-04-23 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A217720-001 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A217720-001 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A217720-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A217720-001 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A217720-001 | AB | 1 | 6a471c1ec25d… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A217720-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Posaconazole | POSACONAZOLE | A2A Integrated Pharmaceuticals | 4d14ceab-196e-4dc3-8b21-5c4629ada161 | 2025-02-28 | Warnings, Adverse reactions | Posaconazole POSACONAZOLE |
| POSACONAZOLE | POSACONAZOLE | Golden State Medical Supply, Inc. | e883b495-d7e7-6d58-e053-2a95a90a1cd3 | 2025-02-24 | Warnings, Adverse reactions | POSACONAZOLE POSACONAZOLE |
| POSACONAZOLE | POSACONAZOLE | Camber Pharmaceuticals, Inc. | c551e121-d5fc-4b35-ba9f-72ce3a314fdc | 2025-01-31 | Warnings, Adverse reactions | POSACONAZOLE POSACONAZOLE |
| Posaconazole | POSACONAZOLE | AvPAK | de95df83-a495-1900-e053-2995a90abf24 | 2025-01-09 | Warnings, Adverse reactions | Posaconazole POSACONAZOLE |
| POSACONAZOLE | POSACONAZOLE | Lannett Company Inc. | 94a9b028-a2bc-4f41-884d-2d6c536881fc | 2024-12-03 | Warnings, Adverse reactions | POSACONAZOLE POSACONAZOLE |
| Posaconazole | POSACONAZOLE | i3 Pharmaceuticals, LLC | d5300d14-219d-4e1e-bfac-b413c40d6e3a | 2024-11-29 | Warnings, Adverse reactions | Posaconazole POSACONAZOLE |
| posaconazole | POSACONAZOLE | Novadoz Pharmaceuticals LLC | 0bdf77ae-3639-49c1-b7c7-533f9d073084 | 2024-09-25 | Warnings, Adverse reactions | posaconazole POSACONAZOLE |
| Posaconazole | POSACONAZOLE | Bryant Ranch Prepack | d2daba09-f1c2-4764-a567-1291be4892b9 | 2024-07-16 | Warnings, Adverse reactions | Posaconazole POSACONAZOLE |
| Posaconazole | POSACONAZOLE | Fresensius Kabi USA, LLC | 86be8cdb-c991-4754-b8f4-1ab79ac40bda | 2023-12-31 | Warnings, Adverse reactions | Posaconazole POSACONAZOLE |
| POSACONAZOLE | POSACONAZOLE DELAYED-RELEASE | Chartwell RX, LLC | f2baa339-75ff-4c03-8334-a88648f701f7 | 2022-12-20 | Warnings, Adverse reactions | POSACONAZOLE |
| Posaconazole | POSACONAZOLE | Camber Pharmaceuticals, Inc. | 573d89eb-05d8-4035-b406-6409f36ab707 | 2022-12-17 | Warnings, Adverse reactions | Posaconazole POSACONAZOLE |
| Posaconazole | POSACONAZOLE | NorthStar RxLLC | 4de6d839-e4bd-405c-83c5-8efc6abd0829 | 2022-12-17 | Warnings, Adverse reactions | Posaconazole POSACONAZOLE |
| POSACONAZOLE | POSACONAZOLE | Biocon Phama Inc. | e0e8023a-3c82-e455-a57b-ccc0206ad156 | 2022-04-27 | Warnings, Adverse reactions | POSACONAZOLE POSACONAZOLE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.